Sunday, September 20, 2026
E-Paper
LOG IN
Daily News Provider
Your Daily, Reliable News Digest
Home
U.S.
Business
Technology
Science
Health
Sports
Crypto
Arts
Nick Paul Taylor
Articles by Nick Paul Taylor
Analysts ‘extremely bullish’ as Telix beams into Novartis’ territory with $1.6B ITM acquisition - Fierce Biotech
Business
September 22, 2026
Novartis stock slides as centerpiece of $12B Avidity buyout flunks ‘crucial’ phase 3 test - Fierce Biotech
Business
September 9, 2026
Bristol Myers Squibb inks $15B biobucks deal to bag Hengrui assets, tap China’s R&D speed - Fierce Biotech
Business
May 13, 2026
Oruka’s psoriasis data hailed as ‘outright win over Skyrizi,’ spurring big blockbuster forecasts - Fierce Biotech
Business
April 28, 2026
J&J's $5B Alzheimer's hope fades as anti-tau antibody posdinemab flops in phase 2 - Fierce Biotech
Business
November 25, 2025
Rocket crashes as gene therapy patient dies, FDA imposes hold - Fierce Biotech
Business
May 28, 2025